Regentis Biomaterials (RGNT.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Oct1

Regentis Biomaterials released FY2025 Semi-Annual Earnings on September 30 (EST) with actual revenue of USD 0 and EPS of USD -1.1775

03:00

Regentis Biomaterials released FY2024 Semi-Annual Earnings on September 30, 2025 (EST) with actual revenue of USD 0 and EPS of USD 2.5955

03:00

Regentis Biomaterials released FY2024 Q1 earnings on September 30 (EST), actual revenue USD 0, actual EPS USD 1.2977

03:00

Sep30

RGNT.US released FY2025 Q2 earnings on September 30, BJT, with actual revenue of USD 0 and EPS of USD -0.5887

15:00

RGNT.US released FY2025 Q1 earnings on September 30 (BJT), actual revenue USD 0, actual EPS USD -0.5887

15:00

Regentis Biomaterials released FY2024 Q2 earnings on September 30, 2025 (EST) with actual revenue of USD 0 and EPS of USD 1.2977

15:00

Schedules & Filings

Schedules

Filings

Sep30

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -95.5 K, EPS -0.5887

Jul7

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -71 K, EPS -0.4377

Mar11

Earning Release(EST)

FY2023 Q2 Earning Release (USD) Net Income -1.655 M, EPS -10.2004

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More